Palo Alto Investors
Palo Alto Investors is an investment advisor founded in 1989 with $1.5 billion under management. The firm's approach is deeply fundamental and their goal is to serve clients by delivering sustained, high rates of return over time. The firm offers several strategies, each of which has the same basic approach and goal, but focus on different market segments.
The firm's investment focus is predominantly Micro-Cap & Small-Cap U.S. Equities and sectors include Technology, Healthcare, Energy, Consumer, & Financial Services.
View Older Stories View More Recent Stories
-
Form SC 13G/A Vanda Pharmaceuticals Filed by: Palo Alto Investors LP
-
Form SC 13G/A STAAR SURGICAL CO Filed by: Palo Alto Investors LP
-
Form SC 13G/A INSMED Inc Filed by: Palo Alto Investors LP
-
Form 13F-HR Palo Alto Investors LP For: Dec 31
-
Form SC 13G/A Karyopharm Therapeutics Filed by: Palo Alto Investors LP
-
Form SC 13G/A Epizyme, Inc. Filed by: Palo Alto Investors LP
-
Form SC 13G/A AMAG PHARMACEUTICALS, Filed by: Palo Alto Investors LP
-
Form SC 13G/A Clovis Oncology, Inc. Filed by: Palo Alto Investors LP
-
Form SC 13G/A ALIMERA SCIENCES INC Filed by: Palo Alto Investors LP
-
Form SC 13G/A Aimmune Therapeutics, Filed by: Palo Alto Investors LP
-
Form 13F-HR Palo Alto Investors LP For: Sep 30
-
Form 13F-HR Palo Alto Investors LP For: Jun 30
-
Form 13F-HR Palo Alto Investors LP For: Mar 31
-
Form 13F-HR/A Palo Alto Investors LP For: Dec 31
-
Form 13F-HR Palo Alto Investors LP For: Dec 31
-
Form SC 13G/A Vanda Pharmaceuticals Filed by: Palo Alto Investors LP
-
Form SC 13G/A Karyopharm Therapeutics Filed by: Palo Alto Investors LP
-
Form SC 13G/A Epizyme, Inc. Filed by: Palo Alto Investors LP
-
Form SC 13G/A STAAR SURGICAL CO Filed by: Palo Alto Investors LP
-
Form SC 13G/A Clovis Oncology, Inc. Filed by: Palo Alto Investors LP
-
Form SC 13G/A INSMED Inc Filed by: Palo Alto Investors LP
-
Form SC 13G/A ALIMERA SCIENCES INC Filed by: Palo Alto Investors LP
-
Form SC 13G/A AMAG PHARMACEUTICALS, Filed by: Palo Alto Investors LP
-
Form SC 13G Aimmune Therapeutics, Filed by: Palo Alto Investors LP
-
Form SC 13D Palo Alto Investors LP Filed by: Palo Alto Investors LP
-
Form SC 13D/A Palo Alto Investors LP Filed by: Palo Alto Investors LP
-
E.A.T Announces Winners of $1 Million Grand Challenge to End Anaphylaxis
-
Form 13F-HR Palo Alto Investors LP For: Sep 30
-
Form 13F-HR Palo Alto Investors LP For: Jun 30
-
Form 13F-HR/A Palo Alto Investors LP For: Mar 31
-
Form 13F-HR Palo Alto Investors LP For: Mar 31
-
End Allergies Together Launches $1 Million Grand Challenge To End Anaphylaxis
-
Yun Family Foundation Announces the Publication of a New Book, Interdependent Capitalism: Redesigning the Social Contract through Inclusive Stakeholding
-
Form SC 13G/A Vanda Pharmaceuticals Filed by: Palo Alto Investors LP
-
Form SC 13G/A STAAR SURGICAL CO Filed by: Palo Alto Investors LP
-
Form SC 13G/A Vanda Pharmaceuticals Filed by: Palo Alto Investors LP
-
Form SC 13G/A Epizyme, Inc. Filed by: Palo Alto Investors LP
-
Form 13F-HR Palo Alto Investors LP For: Dec 31
-
Form SC 13G/A AMAG PHARMACEUTICALS Filed by: Palo Alto Investors LP
-
Form SC 13G/A Karyopharm Therapeutics Filed by: Palo Alto Investors LP
-
Form SC 13G/A INSMED Inc Filed by: Palo Alto Investors LP
-
Form SC 13G/A Clovis Oncology, Inc. Filed by: Palo Alto Investors LP
-
Form SC 13G/A ALIMERA SCIENCES INC Filed by: Palo Alto Investors LP
-
Yun Family Foundation sponsors an incentive prize on incentives -- a $10,000 research paper prize on the research topic "Inclusive Stakeholding: Reimagining Incentives to Promote the Greater Good
-
Form 13F-HR Palo Alto Investors LP For: Sep 30
-
Form 13F-HR Palo Alto Investors LP For: Jun 30
-
Form SC 13G/A Clovis Oncology, Inc. Filed by: Palo Alto Investors LP
